美国 FDA 称该国静脉注射盐水短缺问题已解决

路透中文
Aug 09, 2025
更新 1-美国 FDA 称该国静脉注射盐水短缺问题已解决

在第 2 段至第 4 段增加背景介绍

路透8月8日 - 美国食品和药物管理局局长马丁-马卡里(Martin Makary)周五表示,美国静脉注射和注射用生理盐水短缺问题现已得到解决。

造成短缺的部分原因是百特国际公司(Baxter International)的BAX.N北卡罗来纳州工厂在去年的海伦飓风中受损

据美国医院协会称,当时 北卡罗来纳州马里恩工厂生产的静脉输液和腹膜透析液占全国供应量的60%,每天达150万袋。

静脉输液可为人体提供营养,或补充因受伤或生病而流失的体液,其短缺已迫使医院减少选择性手术。

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10